Skip to main content
. Author manuscript; available in PMC: 2023 Jun 23.
Published in final edited form as: Nature. 2023 Feb 1;614(7947):349–357. doi: 10.1038/s41586-022-05661-6

Extended Data Fig. 10 |. ATP usage in tumours versus healthy tissues, and experimental sample sizes.

Extended Data Fig. 10 |

(a) Total ATP synthesis flux calculated from glucose use flux and TCA flux is similar to the predicted cost of protein ATP synthesis calculated from protein synthesis rates measured using [U-13C] valine infusion in pancreas and pancreatic tumours; n = 13 mice for pancreas, n = 3 for GEMM PDAC, n = 4 for flank PDAC; bars shown mean +/− standard deviation. (b) Adjusted p values of two most significantly enriched KEGG pathways for the genes downregulated in human tumours compared to the corresponding healthy tissue; n = 167 patients for healthy pancreas, n = 178 pancreatic tumour, n = 140 for healthy kidney, n = 884 for kidney tumour, n = 50 for healthy liver, n = 360 for liver tumour; data from UCSC Xena database. (c) Experimental replicates for all experiments shown in this study. Each replicate is a separate mouse tissue. All healthy tissues are from non-tumour bearing mice.